fludarabine and acetylcysteine

fludarabine has been researched along with acetylcysteine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Acquaah-Mensah, GK; Biswal, SS; Datta, K; Kehrer, JP1
Enosawa, S; Haga, S; Ohnuma, N; Ozaki, M; Terui, K1

Other Studies

4 other study(ies) available for fludarabine and acetylcysteine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Changes in ceramide and sphingomyelin following fludarabine treatment of human chronic B-cell leukemia cells.
    Toxicology, 2000, Nov-23, Volume: 154, Issue:1-3

    Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Carboxylic Acids; Caspase 3; Caspase Inhibitors; Caspases; Ceramides; Chromatography, Thin Layer; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fumonisins; Glutathione; Humans; Image Processing, Computer-Assisted; Leukemia, Lymphocytic, Chronic, B-Cell; Phosphatidylserines; Sphingomyelins; Tumor Cells, Cultured; Vidarabine

2000
Hypoxia/re-oxygenation-induced, redox-dependent activation of STAT1 (signal transducer and activator of transcription 1) confers resistance to apoptotic cell death via hsp70 induction.
    The Biochemical journal, 2004, May-15, Volume: 380, Issue:Pt 1

    Topics: Acetylcysteine; Animals; Apoptosis; Cell Hypoxia; Cells, Cultured; DNA-Binding Proteins; Enzyme Inhibitors; Fibroblasts; Gene Expression Regulation; Hepatocytes; HSP70 Heat-Shock Proteins; Janus Kinase 2; Male; MAP Kinase Signaling System; Oxidation-Reduction; Oxidative Stress; Oxygen; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred Lew; STAT1 Transcription Factor; Trans-Activators; Tyrphostins; Vidarabine

2004